Efficacy of Ravuconazole in Treatment of Mucosal Candidosis in SCID Mice
A model of orogastric candidosis in SCID mice, which mimics disease seen in AIDS patients, was used to evaluate ravuconazole in comparison with fluconazole for treatment. Mice were infected orally with Candida albicans and received either no treatment or oral treatment once daily for 12 days with 1,...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
2001
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90849/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11709320/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.12.3433-3436.2001 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
